Literature DB >> 34253177

Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions.

Yuanxing Li1,2, Haixia Luo1,2, Xiu Zhang1,2, Jingjing Chang1,2, Yueyang Zhao1, Jing Li1, Dongyan Li1, Wei Wang3.   

Abstract

BACKGROUND: In the absence of practical and reliable predictors for whether the endocervical curettage (ECC) procedure should be performed, decisions regarding patient selection are usually based on the colposcopists' clinical judgment instead of evidence. We aimed to develop and validate a practical prediction model that uses available information to reliably estimate the need to perform ECC in patients suspected of having cervical lesions.
METHODS: In this retrospective study, 2088 patients who underwent colposcopy, colposcopically directed biopsy (CDB) and ECC procedures between September 2019 and September 2020 at the Second Hospital of Shanxi Medical University were included. The data were analyzed with univariate and multivariable logistic regression. Least absolute shrinkage and selection operator (LASSO) was used to select predictors for ECC positivity. The ECC prediction model was presented as a nomogram and evaluated in terms of discrimination and calibration. Furthermore, this model was validated internally with cross-validation and bootstrapping.
RESULTS: Significant trends were found for ECC positivity with increasing age (P = 0.001), menopause (P = 0.003), Human papillomavirus (HPV) status (P < 0.001), severity of ThinPrep Cytological Test (TCT) (P < 0.001), original squamous epithelium ectopia (P = 0.037) and colposcopy impression (P < 0.001) by multivariable logistic regression analysis. The ECC prediction model was developed based on the following predictors: age, menopause, symptom of contact bleeding, severity of TCT, HPV status, cervix visibility, original squamous epithelium ectopia, acetowhite changes and colposcopic impression. This model had satisfactory calibration and good discrimination, with an area under the receiver operator characteristic curve (AUC) of 0.869 (95% confidence interval 0.849 to 0.889).
CONCLUSIONS: A readily applicable clinical prediction model was constructed to reliably estimate the probability of ECC positivity in patients suspicious of having cervical lesions, which may help clinicians make decisions regarding the ECC procedure and possibly prevent adverse effects.
© 2021. The Author(s).

Entities:  

Keywords:  Cervical cancer; Decision-making; Endocervical curettage; Nomogram; Preoperative factors

Year:  2021        PMID: 34253177     DOI: 10.1186/s12885-021-08523-y

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  16 in total

1.  Evidence for the usefulness of nomograms.

Authors:  Michael W Kattan; Peter T Scardino
Journal:  Nat Clin Pract Urol       Date:  2007-11-06

Review 2.  The Pap Test and Bethesda 2014. "The reports of my demise have been greatly exaggerated." (after a quotation from Mark Twain).

Authors:  Ritu Nayar; David C Wilbur
Journal:  Acta Cytol       Date:  2015-05-19       Impact factor: 2.319

3.  Colposcopy for postmenopausal women.

Authors:  Y Kishi; S Inui; Y Sakamoto; T Mori
Journal:  Gynecol Oncol       Date:  1985-01       Impact factor: 5.482

4.  Endocervical curettage in evaluating abnormal cervical cytology.

Authors:  C W Moniak; S Kutzner; E Adam; J Harden; R H Kaufman
Journal:  J Reprod Med       Date:  2000-04       Impact factor: 0.142

5.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

6.  Serum lncRNAs (CCAT2, LINC01133, LINC00511) with Squamous Cell Carcinoma Antigen Panel as Novel Non-Invasive Biomarkers for Detection of Cervical Squamous Carcinoma.

Authors:  Wen-Jie Wang; Di Wang; Mei Zhao; Xiao-Jie Sun; Yan Li; Hong Lin; Yi-Qun Che; Chang-Zhi Huang
Journal:  Cancer Manag Res       Date:  2020-10-01       Impact factor: 3.989

7.  How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study.

Authors:  Ida J Korfage; Marie-Louise Essink-Bot; Steven M Westenberg; Theo Helmerhorst; J Dik F Habbema; Marjolein van Ballegooijen
Journal:  Gynecol Oncol       Date:  2013-11-09       Impact factor: 5.482

Review 8.  Natural history and epidemiology of HPV infection and cervical cancer.

Authors:  Xavier Castellsagué
Journal:  Gynecol Oncol       Date:  2008-09       Impact factor: 5.482

9.  Adjunct p16(INK4a) immunohistochemistry aids the detection of high-grade squamous intraepithelial lesions in endocervical curettage specimens.

Authors:  Akeesha A Shah; Susanne K Jeffus; Zimin Zhao; Mark H Stoler; Edward B Stelow
Journal:  Am J Clin Pathol       Date:  2014-03       Impact factor: 2.493

10.  A retrospective analysis of the utility of endocervical curettage in screening population.

Authors:  Yan Song; Yu-Qian Zhao; Ling Li; Qin-Jin Pan; Nan Li; Fang-Hui Zhao; Wen Chen; Xun Zhang; You-Lin Qiao
Journal:  Oncotarget       Date:  2017-07-25
View more
  1 in total

1.  Development and validation of a predictive model for endocervical curettage in patients referred for colposcopy: A multicenter retrospective diagnostic study in China.

Authors:  Peng Xue; Bingrui Wei; Samuel Seery; Qing Li; Zichen Ye; Yu Jiang; Youlin Qiao
Journal:  Chin J Cancer Res       Date:  2022-08-30       Impact factor: 4.026

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.